PUBLICATIONS DES MEMBRES

Detection of inherited mutations for hereditary cancer using target enrichment and next generation sequencing
2014 - Guan Y,Hu H,Peng Y,Gong Y,Yi Y,Shao L,Liu T,Li G,Wang R,Dai P,Bignon YJ,Xiao Z,Yang L,Mu F,Xiao L,Xie Z,Yan W,Xu N,Zhou D,YYi X Fam Cancer n°24 - pp 10
Diet-induced hypoxia responsive element demethylation increases CEACAM6 expression, favouring Crohn's disease-associated Escherichia coli colonisation
2014 - Denizoot J,Desrichard A,Agus A,Uhrhammer N,Dreux N,Vouret-Craviari V,Hofman P,Darfeuille-Michaud A,Barnich N Gut n°4 - pp 12
Efficacy and tolerance of one-third full dose bacillus Calmette-Guerin maintenance therapy every 3 months or 6 months:two-year results of URO-BCG-4 multicenter study
2014 - Pfister C,Kerkeni W,Rigaud J,Legal S,Saint F,Colombel M,Guy L,Wallerand H,Irani J,Soulie M Int J Urol n°25 - pp 8
Eligibility criteria for intraoperative radiotherapy for breast cancer:study employing 12025 patients treated in two cohorts
2014 - Zioueche-Mottet A,Houvenaeghel G,Classe JM,Garbay JR,Giard S,Charitansky H,Cohen M,Belicahrd C,Faure C,Chereau-Ewald E,Hudry D,Azuar P,Villet R,Gimbergues P,Tunondelara C,Tallet A,Bannier M,Minsat M,Lambaudie E,Resbeut M BMC Cancer n°14 - pp 1
Epidemiology and risk factors of bladder and urothelial tumors
2014 - Guillaume L,Guy L Rev Prat n°10 - pp 1378-80
Epigenetic mechanisms of breast cancer: an update of the current knowledge
2014 - Karsli-Ceppioglu S,Dagdemir A,Judes G,Ngollo M,Penault-Llorca F,Pajon A,Bignon YJ,Bernard-Gallon D Epigenomics n°6 - pp 651-664
Epigenetic modifications in prostate cancer
2014 - Ngollo M,Dagdemir A,Karsli-Ceppioglu S,Judes G,Pajon A,Penault-llorca F,Boiteux JP,Bignon YJ,Guy L,Bernard-Gallon DJ Epigenomics n°6(4) - pp 415-426
Epigenetics of prostate cancer : distribution of histone H3K27me3 biomarkers in peri-tumoral tissue
2014 - Ngollo M,Dagdemir A,Judes G,Kemeny JL,Penault-Llorca F,Boiteux JP,Lebert A,Bignon YJ,Guy L,Bernard-Gallon D OMICS n°18 - pp 207-209
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
2014 - Cardoso F,Costa A,Norton L,Penault-Llorca F,Piccart MJ,Rugo H,Sledge G Ann Oncol n°25 - pp 1871-1888
ESO-ESMO nd international consensus guidelines for advanced breast cancer (ABC2)
2014 - Cardoso F,Costa A,Norton L,Senkus E,Aapro M,Andre F,Barrios CH,Bergh J,Biganzoli L,Penault-Llorca F,Piccart MF Breast n°23 - pp 489-502
Genomic variations integrated database for MUTYH-associated adenomatous polyposis
2014 - Grandval P,Fabre AJ,Gaildrat P,Baert-Desurmont S,Blayau M,Buisine MP,Coulet F,Maugard C,Pinson S,Remenieras A,Rouleau E,Uhrhammer N,Beroud C,Olschwang S J Med Genet n°3 - pp 4
Harmonization of the evaluation of tumor infiltrating lymphocyes (TILs) in breast cancer:recommendations by an international TIL-working group 2014
2014 - Salgado R,Denkert C,Demaria S,Sirtaine N,Klauschen F,Pruneri G,Wienert S,Vandeneyden G,Baehne FL,Penault-Llorca F,Perez EA,Thompson EA Ann Oncol n°11 - pp 48
HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity
2014 - Hanna WM,Ruschoff J,Bilous M,Coudry RA,Dowsett M,Osamura RY,Penault-Llorca F,Vandevijver M,Viale G Mod Pathol n°27 - pp 4-18
Her3 as biomarker and therapeutic target in pancreatic cancer:new insights in pertuzumab therapy in preclinical models
2014 - Thomas G,Chardes T,Gaborit N,Mollevi C,Leconet W,Robert B,Radosevic-Robin N,Penault-llorca F,Gongora C,Colombo PE,Lazrek Y,Bras-Goncalves R,Savina A,Azria D,Bazin H,Pelegrin A,Larbouret C Oncotarget n°5 - pp 7138-7148
Hibernoma:a clinical model for exploring the role of brown adipose tissue in the regulation of body weight
2014 - Gadea E,Thivat E,Paulon R,Mishellany F,Gimbergues P,Capel F,Mosoni L,Merlin C,Lombes M,Morio B,Durando X J Clin Endocrinol Metab n°99 - pp 1-6
Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy
2014 - Manceau G,Imbeaud S,Thiebaut R,Liebaert F,Fontaine K,Rousseau F,Genin B,Corre DL,Didelot A,Vincent M,Bachet JB,Chibaudel B,Bouche O,Landi B,Bibeau F,Leroy K,Penault-Llorca F,Vanlaethem JL,Demetter P Clin Cancer Res n°20 - pp 3338-3347
Immunonutrition stimulates immune functions and antioxidant defense capacities of leukocytes in radiochemotherapy-treated head & neck and esophageal cancer patients: A double-blind randomized clinical trial
2014 - Talvas J,Garrait G,Goncalves-Mendes N,Rouanet J,Vergnaud-Gauduchon J,Kwiatkowski F,Bachmann P,Bouteloup C,Bienvenu J,Vasson MP Clin Nutr n°9 - pp 8
Incorporation of Pazopanib in maintenance therapy of ovarian cancer
2014 - Dubois A,Floquet A,Kim JW,Rau J,Delcampo JM,Friedlander M,Pignata S,Fujiwara K,Vergote I,Colombo N,Mirza MR,Monk BJ,Kimming R,Ray-Coquard I,Zang R,Diaz-Padilla I,Baumann KH,Mouret-Reynier MA,Kim JH J Clin Oncol n°15 - pp 13
Instant-quality fluorescence in-situ hybridization as a new tool for HER2 testing in breast cancer: a comparative study
2014 - Franchet C,Filleron T,Cayre A,Mounie E,Penault-Llorca F,Jacquemier J,Macgrogan G,Arnould L,Lacroix-Tricki M Histopathology n°64 - pp 274-283
L'ajout d'anthracycline en traitement de rattrapage ne permet pas d'éradiquer la maladie résiduelle médullaire dans le neuroblastoma de haut risque
2014 - Chambon F,Tchirkov A,Merlin E,Pereira B,Rochette E,Ducassou S,Piguet C,Gandemer V,Schneider P,Rubie H,Kanold J Revue d'oncologie hematologie pediatrique n°2 - pp 150-153